Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FH-MCVA2TCR |
Trade Name | |
Synonyms | |
Drug Descriptions |
FH-MCVA2TCR cells are autologous T-lymphocytes that are engineered to express a T-cell receptor that targets MCPyV, which potentially results in an anti-tumor immune response and inhibition of tumor cell proliferation (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C156382 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + FH-MCVA2TCR | Avelumab FH-MCVA2TCR | 0 | 1 |
FH-MCVA2TCR | FH-MCVA2TCR | 0 | 0 |